Cargando…
Transcriptome profiling of patient-derived tumor xenografts suggests novel extracellular matrix-related signatures for gastric cancer prognosis prediction
BACKGROUND: A major obstacle to the development of personalized therapies for gastric cancer (GC) is the prevalent heterogeneity at the intra-tumor, intra-patient, and inter-patient levels. Although the pathological stage and histological subtype diagnosis can approximately predict prognosis, GC het...
Autores principales: | Deng, Ziqian, Guo, Ting, Bi, Jiwang, Wang, Gangjian, Hu, Ying, Du, Hong, Zhou, Yuan, Jia, Shuqin, Xing, Xiaofang, Ji, Jiafu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510236/ https://www.ncbi.nlm.nih.gov/pubmed/37726803 http://dx.doi.org/10.1186/s12967-023-04473-0 |
Ejemplares similares
-
TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance
por: Ma, Xiaoxiao, et al.
Publicado: (2023) -
EPLIN Expression in Gastric Cancer and Impact on Prognosis and Chemoresistance
por: Gong, Wenjing, et al.
Publicado: (2021) -
Progressive and Prognostic Performance of an Extracellular Matrix-Receptor Interaction Signature in Gastric Cancer
por: Yang, Xiangchou, et al.
Publicado: (2020) -
Extracellular Matrix Characterization in Gastric Cancer Helps to Predict Prognosis and Chemotherapy Response
por: Yang, Zhi, et al.
Publicado: (2021) -
Extracellular matrix-based gene signature for predicting prognosis in colon cancer and immune microenvironment
por: Chai, Ruoyang, et al.
Publicado: (2023)